Biomime Stent in All-comers PCI Patients Registry (BELLINI)

University Hospital Maggiore della Carità of Novara

Status: Unknown

Conditions: Coronary Artery Disease

Treatments: Device: percutaneous coronary intervention

Study type: Observational

Funder types: Other

Identifiers

NCT02398955

BELLINI01

Details and patient eligibility

About

Biomime stent is a novel sirolimus-eluting stent (SES) (Meril Life Sciences Pvt. Ltd., Gujarat, India) with an ultra-thin stent platform (65 μm) and a biodegradable polymer licensed for the treatment of de novo coronary lesions. However no data regarding the efficacy and safety of this stent in an "all-comers" patient population treated with percutaneus coronary interventions (PCI) have been published so far. In this registry the investigators aimed to collect clinical and angiographic information about an extensive "all-comers" employ of this novel stent.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• any coronary artery disease treated with percutaneous coronary intervention and a Biomime stent

Exclusion criteria

• patients <18 years old

Trial design

250 participants in 1 patient group

Study cohort

Description:

All comers patients with coronary artery disease treated with percutaneous coronary intervention and at least one Biomime stent

Treatment:

Device: percutaneous coronary intervention